AM-2201– synthetic, CB1 agonist


Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction                        (abst – 2012)


First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.                             (abst – 2012)


Identification and Structural Elucidation of Four Cannabimimetic Compounds (RCS-4, AM-2201, JWH-203 and JWH-210) in Seized Products.                          (abst – 2013)




Share a link for